Lindsey Korbel1, John David Spencer2. 1. The Ohio State University College of Medicine, Center for Clinical and Translational Research. 2. The Research Institute at Nationwide Children's, Center for Clinical and Translational Research. Electronic address: john.spencer@nationwidechildrens.org.
Abstract
AIMS: The objective of this study is to evaluate the number of diabetics that seek medical treatment in emergency departments or require hospitalization for infection management in the United States. This study also assesses the socioeconomic impact of inpatient infection management among diabetics. METHODS: We accessed the Healthcare Cost and Utilization Project's Nationwide Emergency Department Sample database and the Nationwide Inpatient Sample database to perform a retrospective analysis on diabetics presenting to the emergency department or hospitalized for infection management from 2006 to 2011. RESULTS: Emergency Department: Since 2006, nearly 10 million diabetics were annually evaluated in the emergency department. Infection was the primary reason for presentation in 10% of these visits. Among those visits, urinary tract infection was the most common infection, accounting for over 30% of emergency department encounters for infections. Other common infections included sepsis, skin and soft tissue infections, and pneumonia. Diabetics were more than twice as likely to be hospitalized for infection management than patients without diabetes. Hospitalization: Since 2006, nearly 6 million diabetics were annually hospitalized. 8-12% of these patients were hospitalized for infection management. In 2011, the inpatient care provided to patients with DM, and infection was responsible for over $48 billion dollars in aggregate hospital charges. CONCLUSIONS: Diabetics commonly present to the emergency department and require hospitalization for infection management. The care provided to diabetics for infection management has a large economic impact on the United States healthcare system. More efforts are needed to develop cost-effective strategies for the prevention of infection in patients with diabetes.
AIMS: The objective of this study is to evaluate the number of diabetics that seek medical treatment in emergency departments or require hospitalization for infection management in the United States. This study also assesses the socioeconomic impact of inpatient infection management among diabetics. METHODS: We accessed the Healthcare Cost and Utilization Project's Nationwide Emergency Department Sample database and the Nationwide Inpatient Sample database to perform a retrospective analysis on diabetics presenting to the emergency department or hospitalized for infection management from 2006 to 2011. RESULTS: Emergency Department: Since 2006, nearly 10 million diabetics were annually evaluated in the emergency department. Infection was the primary reason for presentation in 10% of these visits. Among those visits, urinary tract infection was the most common infection, accounting for over 30% of emergency department encounters for infections. Other common infections included sepsis, skin and soft tissue infections, and pneumonia. Diabetics were more than twice as likely to be hospitalized for infection management than patients without diabetes. Hospitalization: Since 2006, nearly 6 million diabetics were annually hospitalized. 8-12% of these patients were hospitalized for infection management. In 2011, the inpatient care provided to patients with DM, and infection was responsible for over $48 billion dollars in aggregate hospital charges. CONCLUSIONS:Diabetics commonly present to the emergency department and require hospitalization for infection management. The care provided to diabetics for infection management has a large economic impact on the United States healthcare system. More efforts are needed to develop cost-effective strategies for the prevention of infection in patients with diabetes.
Authors: L M A J Muller; K J Gorter; E Hak; W L Goudzwaard; F G Schellevis; A I M Hoepelman; G E H M Rutten Journal: Clin Infect Dis Date: 2005-06-16 Impact factor: 9.079
Authors: Andrea C Tricco; Noah M Ivers; Jeremy M Grimshaw; David Moher; Lucy Turner; James Galipeau; Ilana Halperin; Brigitte Vachon; Tim Ramsay; Braden Manns; Marcello Tonelli; Kaveh Shojania Journal: Lancet Date: 2012-06-09 Impact factor: 79.321
Authors: Tad E Eichler; Brian Becknell; Robert S Easterling; Susan E Ingraham; Daniel M Cohen; Andrew L Schwaderer; David S Hains; Birong Li; Ariel Cohen; Jackie Metheny; Susheela Tridandapani; John David Spencer Journal: Kidney Int Date: 2016-07-09 Impact factor: 10.612
Authors: Rahul D Barmanray; Nathan Cheuk; Spiros Fourlanos; Peter B Greenberg; Peter G Colman; Leon J Worth Journal: BMJ Open Diabetes Res Care Date: 2022-07
Authors: Kristin Bender; Laura L Schwartz; Ariel Cohen; Claudia Mosquera Vasquez; Matthew J Murtha; Tad Eichler; Jason P Thomas; Ashley Jackson; John David Spencer Journal: Am J Physiol Renal Physiol Date: 2021-04-05
Authors: Matthew J Murtha; Tad Eichler; Kristin Bender; Jackie Metheny; Birong Li; Andrew L Schwaderer; Claudia Mosquera; Cindy James; Laura Schwartz; Brian Becknell; John David Spencer Journal: J Clin Invest Date: 2018-11-12 Impact factor: 19.456
Authors: Ana López-de-Andrés; Valentín Hernández-Barrera; Maria A Martínez-Huedo; Manuel Villanueva-Martinez; Isabel Jiménez-Trujillo; Rodrigo Jiménez-García Journal: PLoS One Date: 2017-08-24 Impact factor: 3.240
Authors: M Martins; J M Boavida; J F Raposo; F Froes; B Nunes; R T Ribeiro; M P Macedo; C Penha-Gonçalves Journal: BMJ Open Diabetes Res Care Date: 2016-05-20